Advisor Group Holdings, Inc. I Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $160.0 $23 - $16,000	100 Added 1.45%	7,012 $1,000
Q1 2022 May 04, 2022	SELL	$0.3 - $0.61 $735 - $1,494	-2,450 Reduced 26.17%	6,912 $3,000
Q3 2021 Nov 05, 2021	SELL	$1.06 - $1.52 $26 - $38	-25 Reduced 0.27%	9,362 $10,000
Q2 2021 Aug 02, 2021	SELL	$1.22 - $1.65 $8,037 - $10,870	-6,588 Reduced 41.24%	9,387 $14,000
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $6,239 - $13,854	5,288 Added 49.48%	15,975 $25,000
Q4 2020 Feb 10, 2021	SELL	$1.05 - $2.24 $300,150 - $640,321	-285,858 Reduced 96.4%	10,687 $12,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $495,529 - $1.87 Million	291,488 Added 5764.05%	296,545 $602,000
Q2 2020 Aug 14, 2020	SELL	$0.87 - $2.46 $16,878 - $47,726	-19,401 Reduced 79.32%	5,057 $11,000
Q1 2020 May 18, 2020	BUY	$0.22 - $2.45 $5,380 - $59,922	24,458 New	24,458 $25,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.